Nanobiotix S.A.
NBTX
$51.50
-$3.57-6.48%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.81M | -10.86M | -3.05M | -2.83M | -24.66M |
| Total Depreciation and Amortization | 403.40K | 405.10K | 452.80K | 419.90K | 442.90K |
| Total Amortization of Deferred Charges | 1.20K | 1.20K | 1.10K | 1.10K | 2.10K |
| Total Other Non-Cash Items | 4.04M | 4.06M | -8.22M | -7.63M | 15.82M |
| Change in Net Operating Assets | -2.95M | -2.96M | 944.80K | 876.10K | 1.08M |
| Cash from Operations | -9.32M | -9.36M | -9.88M | -9.16M | -7.31M |
| Capital Expenditure | -225.80K | -226.80K | -85.10K | -78.90K | -190.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -16.30K | -16.40K | -6.80K | -6.30K | -52.20K |
| Cash from Investing | -242.10K | -243.20K | -91.90K | -85.20K | -242.50K |
| Total Debt Issued | 21.47M | 21.47M | -- | -- | -- |
| Total Debt Repaid | -1.13M | -1.13M | -1.25M | -1.25M | -1.05M |
| Issuance of Common Stock | 767.50K | 767.50K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -986.00K | -986.00K | -168.00K | -168.00K | -185.50K |
| Cash from Financing | 23.43M | 23.53M | -1.61M | -1.49M | -1.32M |
| Foreign Exchange rate Adjustments | 65.80K | 66.10K | -292.20K | -271.00K | 27.20K |
| Miscellaneous Cash Flow Adjustments | 600.00 | 600.00 | -600.00 | -500.00 | -- |
| Net Change in Cash | 13.93M | 13.99M | -11.87M | -11.01M | -8.85M |